Aaron Berutti - 09 Mar 2023 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Sr. VP, Sales
Signature
/s/ Lisa Taylor as Attorney-in-fact for Aaron Berutti
Issuer symbol
TMCI
Transactions as of
09 Mar 2023
Net transactions value
-$17,893
Form type
4
Filing time
10 Mar 2023, 20:00:24 UTC
Previous filing
21 Nov 2022
Next filing
12 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $17,893 -733 -5.3% $24.41 13,042 09 Mar 2023 Direct F1, F2
transaction TMCI Common Stock Award $0 +29,800 +228% $0.000000 42,842 10 Mar 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +67,500 $0.000000 67,500 10 Mar 2023 Stock Option (Right to Buy) 67,500 $24.07 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 Includes 8,962 RSUs.
F3 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 Includes 38,762 RSUs.
F5 The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.